サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1504966

がん治療用臨床栄養市場、シェア、規模、動向、産業分析レポート：タイプ別、がんタイプ別、年齢層別、販売チャネル別、地域別、セグメント別予測、2024年～2032年

Clinical Nutrition for Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Type; By Cancer Type; By Age Group; By Sales Channel, By Region; Segment Forecast, 2024- 2032

出版日
ページ情報
英文 119 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
がん治療用臨床栄養市場、シェア、規模、動向、産業分析レポート：タイプ別、がんタイプ別、年齢層別、販売チャネル別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年05月01日
発行: Polaris Market Research
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、がん治療用臨床栄養の世界市場規模は2032年までに71億1,000万米ドルに達する見込みです。本レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

必要量の栄養素を供給することでがん患者の免疫力を向上させる栄養サポート製品の能力が、市場成長の主な原因となっています。さらに、新製品の発売、合併、買収、提携、パートナーシップなどの戦略的イニシアチブの実施が市場成長に寄与しています。例えば、2024年1月、Danone Nutricia社は、がん患者向けの栄養サポートモジュールを開発するため、Resilience社との新たな提携を発表しました。このような戦略的な取り組みにより、今後数年間は栄養ががん治療の不可欠な一部となると思われます。

座りがちなライフスタイル、運動不足、遺伝は、がんの主な原因の一部です。がん疾患の有病率の増加、がん患者における栄養不良の発生率の増加、がん治療センターのインフラの改善、さまざまな種類のがん治療のための入院患者数の増加は、がん治療用臨床栄養市場の成長をもたらす主な要因の一部です。例えば、世界保健機関（WHO）が発表した統計によると、2022年には世界115カ国で2,000万人の新規がん患者が発生すると推定されています。

個別化治療に対する高い需要、がん治療中に栄養状態を評価する必要性の高まり、より良い治療結果をもたらす効果的な栄養補助食品の登場は、予測期間中に市場に貢献すると予想されます。さらに、免疫腫瘍学治療を受けているがん患者の免疫システムを修正する必要性が、がん用栄養補助食品の需要を増加させる見込みです。さらに、補完的な治療法としてのがん栄養についてヘルスケア従事者を教育することにメーカーが注力する傾向が高まっていることも、今後数年間の市場成長を後押しすると思われます。

がん治療用臨床栄養市場レポート・ハイライト

経口サプリメントががん患者に提供する摂取のしやすさや利便性などの利点により、経口栄養剤の分野が市場を独占しています。

肺がん分野は、先進国における肺がんの高い有病率に起因して、大きなCAGRで拡大すると予想されます。

成人がん患者の栄養不良の発生率が増加していることから、2023年には成人市場が世界市場を独占しました。

オンライン販売への嗜好の高まりにより、オンライン・セグメントが最も高いCAGRを記録すると予測されます。

北米が最大の市場シェアを占めたのは、がん患者の有病率の高さと、がん治療前の栄養状態評価のニーズの高まりによるものです。

市場参入企業には、Nestle Health Science社、Abbott Nutrition社、Danone Nutricia社、Bayer AG社、Baxter社などがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 がん治療用臨床栄養の世界市場の洞察

  • がん治療用臨床栄養学-業界スナップショット
  • がん治療用臨床栄養市場力学
    • 促進要因と機会
      • がん患者のがん負担の増加と栄養失調リスクの上昇が市場の成長を牽引している
      • がん治療における栄養の潜在的な利点は市場の成長に有益であることが証明される
    • 抑制要因と課題
      • 腫瘍栄養学における臨床的証拠の欠如により、がん治療用臨床栄養市場の拡大が制限されている
  • PESTLE分析
  • がん治療における臨床栄養業界の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のがん治療用臨床栄養市場：タイプ別

  • 主な調査結果
  • イントロダクション
  • 経口栄養
  • 経腸栄養
  • 経腸栄養剤

第6章 世界のがん治療用臨床栄養市場：がんタイプ別

  • 主な調査結果
  • イントロダクション
  • 頭頸部がん
  • 胃がんおよび消化器がん
  • 血液がん
  • 乳がん
  • 肺がん
  • その他

第7章 世界のがん治療用臨床栄養市場：年齢層別

  • 主な調査結果
  • イントロダクション
  • 成人
  • 小児

第8章 世界のがん治療用臨床栄養市場：販売チャネル別

  • 主な調査結果
  • イントロダクション
  • オフライン
  • オンライン

第9章 世界のがん治療用臨床栄養市場：地域別

  • 主な調査結果
  • イントロダクション
    • がん治療用臨床栄養市場評価：地域、2019-2032年
  • 北米
    • 北米：タイプ別、2019-2032年
    • 北米：販売チャネル別、2019-2032年
    • 北米：がんタイプ別、2019-2032年
    • 北米：年齢別、2019-2032年
    • 米国
    • カナダ
  • 欧州
    • 欧州：タイプ別、2019-2032
    • 欧州：販売チャネル別、2019-2032年
    • 欧州：がんタイプ別、2019-2032年
    • 欧州：年齢別、2019-2032年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
  • アジア太平洋地域
    • アジア太平洋地域：タイプ別、2019-2032
    • アジア太平洋地域：販売チャネル別、2019-2032年
    • アジア太平洋地域：がんタイプ別、2019-2032年
    • アジア太平洋地域：年齢別、2019-2032年
    • 中国
    • インド
    • 日本
    • マレーシア
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 中東・アフリカ：タイプ別、2019-2032年
    • 中東・アフリカ：販売チャネル別、2019-2032年
    • 中東・アフリカ：がんタイプ別、2019-2032年
    • 中東・アフリカ：年齢別、2019-2032年
    • サウジアラビア
    • 南アフリカ
    • イスラエル
    • アラブ首長国連邦
  • ラテンアメリカ
    • ラテンアメリカ：タイプ別、2019-2032年
    • ラテンアメリカ：販売チャネル別、2019-2032年
    • ラテンアメリカ：がんタイプ別、2019-2032年
    • ラテンアメリカ：年齢別、2019-2032年
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第11章 企業プロファイル

  • Abbott Nutrition（U.S.）
  • Baxter（U.S.）
  • Bayer AG（Germany）
  • Danone Nutricia（The Netherlands）
  • GlaxoSmithKline plc（UK）
  • Medtrition, Inc.（U.S.）
  • Nestle Health Science（Switzerland）
  • Otsuka Holdings Co., Ltd.（Japan）
  • Pfizer Inc.（U.S.）
  • Victus, Inc.（U.S.）
図表

List of Tables

  • Table 1 Global Clinical Nutrition for Cancer Care Market, by Type, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Clinical Nutrition for Cancer Care Market, by Cancer Type, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Clinical Nutrition for Cancer Care Market, by Age Group, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Clinical Nutrition for Cancer Care Market, by Sales Channel, by Region, 2019-2032 (USD Billion)
  • Table 5 Clinical Nutrition for Cancer Care Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 7 North America: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 8 North America: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 9 North America: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 10 U.S.: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 11 U.S.: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 12 U.S.: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 13 U.S.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 14 Canada: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 15 Canada: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 16 Canada: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 17 Canada: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 18 Europe: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 19 Europe: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 20 Europe: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 21 Europe: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 22 Germany: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 23 Germany: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 25 Germany: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 26 France: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 27 France: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 28 France: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 29 France: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 30 UK: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 31 UK: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 32 UK: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 33 UK: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 34 Italy: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 35 Italy: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 36 Italy: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 37 Italy: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 42 Spain: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 43 Spain: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 44 Spain: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 45 Spain: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 46 Russia: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 47 Russia: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 48 Russia: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 49 Russia: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 54 China: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 55 China: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 56 China: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 57 China: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 58 Japan: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 59 Japan: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 60 Japan: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 61 Japan: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 62 India: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 63 India: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 64 India: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 65 India: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 74 South Korea: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 75 South Korea: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 76 South Korea: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 77 South Korea: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 78 Latin America: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 79 Latin America: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 80 Latin America: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 81 Latin America: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 82 Brazil: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 83 Brazil: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 84 Brazil: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 85 Brazil: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 86 Mexico: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 87 Mexico: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 88 Mexico: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 89 Mexico: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 90 Argentina: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 91 Argentina: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 92 Argentina: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 93 Argentina: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 98 UAE: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 99 UAE: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 100 UAE: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 101 UAE: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 106 South Africa: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 107 South Africa: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 108 South Africa: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 109 South Africa: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • Table 110 Israel: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • Table 111 Israel: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 112 Israel: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • Table 113 Israel: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Clinical Nutrition for Cancer Care Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Sales Channel
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Clinical Nutrition for Cancer Care Market, by Type, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Sales Channel
  • Figure 9. Global Clinical Nutrition for Cancer Care Market, by Sales Channel, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Cancer Type
  • Figure 11. Global Clinical Nutrition for Cancer Care Market, by Cancer Type, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Age Group
  • Figure 13. Global Clinical Nutrition for Cancer Care Market, by Age Group, 2021 & 2030 (USD Billion)
目次
Product Code: PM4926

The global clinical nutrition for cancer care market size is expected to reach USD 7.11 billion by 2032, according to a new study by Polaris Market Research. The report "Clinical Nutrition for Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Type (Oral Nutrition, Parenteral Nutrition, and Enteral Feeding Formulas); By Cancer Type; By Age Group; By Sales Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The ability of nutritional support products to improve the immunity of cancer patients by providing the required amount of nutrients is primarily responsible for the market growth. Moreover, the implementation of strategic initiatives such as new product launches, merges, acquisitions, alliance, and partnerships contribute to the market growth. For instance, in January 2024, Danone Nutricia announced a new partnership with Resilience to develop nutritional support module for patients with cancer. Such strategic initiatives will make nutrition an integral part of oncology treatment in the coming years.

Sedentary lifestyle, lack of physical activity, and inheritance are some of main causes of cancer. Growing prevalence of cancer disease, increasing incidence of malnourishment among cancer patients, improving infrastructure of cancer care centers, and rising hospital admissions for the treatment of various types of cancer are some of the major factors responsible for the growth of clinical nutrition for cancer care market. For instance, according as per the fact & figures published by the World Health Organization (WHO), in 2022, an estimated 20 million new cancer cases were reported in 115 countries across the world.

High demand for personalized treatment, rising need to assess nutritional status during cancer therapy, and the advent of effective nutritional supplements with better treatment outcomes are expected to contribute to the market during the forecast period. Moreover, the necessity to modify the immune system among the cancer patients receiving immune-oncology treatment will increase the demand for nutritional supplements for cancer. Furthermore, rising focus of manufacturers towards educating healthcare practitioners on cancer nutrition as a complementary treatment will boost the market growth in the upcoming years.

Clinical Nutrition for Cancer Care Market Report Highlights

The oral nutrition segment dominated the market, owing to the benefits such as ease of consumption and convenience offered by oral supplements to cancer patients.

The lung cancer segment is expected to expand at the significant CAGR, owing to the high prevalence of lung cancer in the developed countries.

The adults segment dominated the global market in 2023, owing to increasing occurrence rate of malnourishment among adult cancer patients.

The online segment is anticipated to register the highest CAGR, owing to the increasing preference to online distribution.

North America held the largest market share, owing to the high prevalence of cancer patients and rising need for assessment of nutritional status before cancer therapy.

The market players include Nestle Health Science, Abbott Nutrition, Danone Nutricia, Bayer AG, and Baxter among others.

Polaris Market Research has segmented the clinical nutrition for cancer care market report based on and region:

Clinical Nutrition for Cancer Care, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oral Nutrition
  • Parenteral Nutrition
  • Enteral Feeding Formulas

Clinical Nutrition for Cancer Care, Cancer Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Head & Neck Cancer
  • Stomach & Gastrointestinal Cancers
  • Blood Cancer
  • Breast Cancer
  • Lung Cancer
  • Others

Clinical Nutrition for Cancer Care, Age Group Outlook (Revenue - USD Billion, 2019 - 2032)

  • Adult
  • Pediatric

Clinical Nutrition for Cancer Care, Sales Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Offline
  • Online

Clinical Nutrition for Cancer Care, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Clinical Nutrition for Cancer Care Market Insights

  • 4.1. Clinical Nutrition for Cancer Care - Industry Snapshot
  • 4.2. Clinical Nutrition for Cancer Care Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing cancer burden and rising risk of malnutrition in oncology patients are driving the market growth
      • 4.2.1.2. Potential benefits of nutrition in cancer treatment will prove beneficial for the market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of clinical evidence in oncology nutrition limits the expansion of clinical nutrition for cancer care market
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Clinical Nutrition for Cancer Care Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Clinical Nutrition for Cancer Care Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Oral Nutrition
    • 5.3.1. Global Clinical Nutrition for Cancer Care Market, by Oral Nutrition, by Region, 2019-2032 (USD Billion)
  • 5.4. Parenteral Nutrition
    • 5.4.1. Global Clinical Nutrition for Cancer Care Market, by Parenteral Nutrition, by Region, 2019-2032 (USD Billion)
  • 5.5. Enteral Feeding Formulas
    • 5.5.1. Global Clinical Nutrition for Cancer Care Market, by Enteral Feeding Formulas, by Region, 2019-2032 (USD Billion)

6. Global Clinical Nutrition for Cancer Care Market, by Cancer Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
  • 6.3. Head & Neck Cancer
    • 6.3.1. Global Clinical Nutrition for Cancer Care Market, by Head & Neck Cancer, by Region, 2019-2032 (USD Billion)
  • 6.4. Stomach & Gastrointestinal Cancers
    • 6.4.1. Global Clinical Nutrition for Cancer Care Market, by Stomach & Gastrointestinal Cancers, by Region, 2019-2032 (USD Billion)
  • 6.5. Blood Cancer
    • 6.5.1. Global Clinical Nutrition for Cancer Care Market, by Blood Cancer, by Region, 2019-2032 (USD Billion)
  • 6.6. Breast Cancer
    • 6.6.1. Global Clinical Nutrition for Cancer Care Market, by Breast Cancer, by Region, 2019-2032 (USD Billion)
  • 6.7. Lung Cancer
    • 6.7.1. Global Clinical Nutrition for Cancer Care Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
  • 6.8. Others
    • 6.8.1. Global Clinical Nutrition for Cancer Care Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Clinical Nutrition for Cancer Care Market, by Age Group

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • 7.3. Adult
    • 7.3.1. Global Clinical Nutrition for Cancer Care Market, by Adult, by Region, 2019-2032 (USD Billion)
  • 7.4. Paediatric
    • 7.4.1. Global Clinical Nutrition for Cancer Care Market, by Paediatric, by Region, 2019-2032 (USD Billion)

8. Global Clinical Nutrition for Cancer Care Market, by Sales Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
  • 8.3. Offline
    • 8.3.1. Global Clinical Nutrition for Cancer Care Market, by Offline, by Region, 2019-2032 (USD Billion)
  • 8.4. Online
    • 8.4.1. Global Clinical Nutrition for Cancer Care Market, by Online, by Region, 2019-2032 (USD Billion)

9. Global Clinical Nutrition for Cancer Care Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Clinical Nutrition for Cancer Care Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Clinical Nutrition for Cancer Care Market - North America
    • 9.3.1. North America: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
    • 9.3.2. North America: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
    • 9.3.3. North America: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
    • 9.3.4. North America: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.3.5. Clinical Nutrition for Cancer Care Market - U.S.
      • 9.3.5.1. U.S.: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.3.6. Clinical Nutrition for Cancer Care Market - Canada
      • 9.3.6.1. Canada: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • 9.4. Clinical Nutrition for Cancer Care Market - Europe
    • 9.4.1. Europe: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.4.5. Clinical Nutrition for Cancer Care Market - UK
      • 9.4.5.1. UK: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.4.6. Clinical Nutrition for Cancer Care Market - France
      • 9.4.6.1. France: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.4.7. Clinical Nutrition for Cancer Care Market - Germany
      • 9.4.7.1. Germany: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.4.8. Clinical Nutrition for Cancer Care Market - Italy
      • 9.4.8.1. Italy: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.4.9. Clinical Nutrition for Cancer Care Market - Spain
      • 9.4.9.1. Spain: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.4.10. Clinical Nutrition for Cancer Care Market - Netherlands
      • 9.4.10.1. Netherlands: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.4.11. Clinical Nutrition for Cancer Care Market - Russia
      • 9.4.11.1. Russia: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • 9.5. Clinical Nutrition for Cancer Care Market - Asia Pacific
    • 9.5.1. Asia Pacific: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.5.5. Clinical Nutrition for Cancer Care Market - China
      • 9.5.5.1. China: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.5.6. Clinical Nutrition for Cancer Care Market - India
      • 9.5.6.1. India: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.5.7. Clinical Nutrition for Cancer Care Market - Japan
      • 9.5.7.1. Japan: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.5.8. Clinical Nutrition for Cancer Care Market - Malaysia
      • 9.5.8.1. Malaysia: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.5.9. Clinical Nutrition for Cancer Care Market - Indonesia
      • 9.5.9.1. Indonesia: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.5.10. Clinical Nutrition for Cancer Care Market - South Korea
      • 9.5.10.1. South Korea: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • 9.6. Clinical Nutrition for Cancer Care Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.6.5. Clinical Nutrition for Cancer Care Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.6.6. Clinical Nutrition for Cancer Care Market - South Africa
      • 9.6.6.1. South Africa: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.6.7. Clinical Nutrition for Cancer Care Market - Israel
      • 9.6.7.1. Israel: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.6.8. Clinical Nutrition for Cancer Care Market - UAE
      • 9.6.8.1. UAE: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
  • 9.7. Clinical Nutrition for Cancer Care Market - Latin America
    • 9.7.1. Latin America: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.7.5. Clinical Nutrition for Cancer Care Market - Mexico
      • 9.7.5.1. Mexico: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.7.6. Clinical Nutrition for Cancer Care Market - Brazil
      • 9.7.6.1. Brazil: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)
    • 9.7.7. Clinical Nutrition for Cancer Care Market - Argentina
      • 9.7.7.1. Argentina: Clinical Nutrition for Cancer Care Market, by Type, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Clinical Nutrition for Cancer Care Market, by Sales Channel, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Clinical Nutrition for Cancer Care Market, by Cancer Type, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Clinical Nutrition for Cancer Care Market, by Age Group, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abbott Nutrition (U.S.)
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Baxter (U.S.)
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Bayer AG (Germany)
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Danone Nutricia (The Netherlands)
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. GlaxoSmithKline plc (UK)
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Medtrition, Inc. (U.S.)
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Nestle Health Science (Switzerland)
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Otsuka Holdings Co., Ltd. (Japan)
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Pfizer Inc. (U.S.)
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Victus, Inc. (U.S.)
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development